Aurora Cannabis Inc.

ACB Healthcare Drug Manufacturers Specialty & Generic

Aurora Cannabis Inc.’s revenue for fiscal 2026 (year ended March 2026) was $232.0 million, down 5.95% from fiscal 2025. In the quarter to June 2026, revenue fell 31.2%, EPS grew 75.0%, free cash flow fell 293.6% and total debt fell 82.5%, each against the same quarter a year earlier.

3.99 0.11 −2.68%
Market cap
$265.8M
P/E
0.0×
Fwd P/E
−783×
Dividend yield
—
F-score
4/9
Altman Z
−12.34
Beneish M
−2.53
Dividend safety
n/a
Mar '26 Mar '25 Mar '24 Jun '23 Jun '22 Jun '21 Jun '20 Jun '19 Jun '18 Jun '17
Piotroski F-Score
4 — — 4 4 5 4 3 — —
P/E ratio
0.00 39.91 0.00 0.00 0.00 0.00 0.00 0.00 1,381.62 0.00
Altman Z-Score
(12.34) (8.69) (9.41) (7.40) (7.12) (0.26) (0.75) 5.50 6.87 3.90
P/S ratio
0.80 0.98 0.93 0.98 16.22 79.86 57.79 424.53 741.08 330.36
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z″-Score (non-manufacturers)
(25.83) (18.86) (20.09) (22.93) (14.31) (0.98) (1.65) 3.86 5.00 5.15
Beneish M-Score
(2.53) (2.59) — — (11.28) — — 0.94 1.88 —
P/Operating CF
(733.60) 89.10 (11.65) (22.63) (32.69) (93.01) (47.69) (547.52) (500.87) (566.83)
P/B ratio
0.50 0.55 0.42 0.50 5.42 9.61 7.58 23.98 26.17 27.20
Price to Tangible BV
0.56 0.64 0.49 0.59 6.07 25.03 20.51 198.93 70.79 40.58
EV/Sales
0.53 0.72 0.62 0.71 15.20 79.65 59.08 425.67 742.05 324.21
EV/EBITDA
0.00 7.93 0.00 0.00 0.00 0.00 0.00 0.00 0.00 305.78
EV/Operating CF
(12.65) 15.51 (2.45) (0.83) (17.43) (44.07) (26.31) (278.37) (378.12) 0.00
EV/FCF
(4.89) (302.77) (2.30) (0.82) (16.48) (38.03) (12.71) (101.55) (90.74) 0.00
Quick Ratio
3.13 2.06 1.83 1.41 3.70 4.31 0.82 1.09 2.19 7.54
Current Ratio
5.94 4.31 3.42 1.98 5.13 5.72 1.54 1.52 2.92 8.25
Net Debt/EBITDA
5.11 (2.77) 8.70 0.35 1.65 0.28 (0.96) (1.25) (0.57) 10.97
Debt/Assets
3.02% 11.63% 11.92% 24.62% 24.29% 15.10% 19.08% 11.72% 10.64% 19.78%
Debt/Equity
0.04 0.16 0.17 0.47 0.40 0.19 0.25 0.15 0.13 0.29
Asset Turnover
0.44 0.40 0.30 0.23 0.12 0.09 0.07 0.07 0.05 0.09
Operating CF/Net income
0.11 7.06 1.04 0.44 0.06 0.30 0.10 0.66 (1.14) 0.81
Capex/Depreciation
(1.19) (0.64) (0.13) 0.00 (0.13) (0.34) (3.06) (4.69) (22.49) (29.87)
Interest Coverage
(25.79) 0.59 (3.27) (26.77) (3.22) (4.26) (6.33) (7.66) (8.05) (1.70)
ROE
(21.82%) 0.37% (11.98%) (44.89%) (128.39%) (34.17%) (100.72%) (9.66%) 8.12% (11.52%)
ROA
(16.82%) 0.26% (7.38%) (25.69%) (93.92%) (26.41%) (79.21%) (7.76%) 6.48% (6.53%)
ROIC
(7.98%) 0.59% (5.60%) 0.00% (33.21%) (8.90%) (12.33%) (4.20%) (4.09%) (6.47%)
Return on Tangible Assets
(26.81%) 0.36% (11.00%) (47.30%) (206.11%) (60.15%) (302.50%) (29.28%) 18.40% (6.01%)
Average Days of Receivables
50.75 45.16 61.33 64.15 77.59 84.06 70.81 165.36 99.83 46.71
Research and Development Expense of Revenue
1.25% 1.07% 1.32% 2.81% 4.69% 4.67% 9.35% 5.96% 3.04% 1.74%
Selling, General and Administrative Expense of Revenue
54.12% 48.49% 58.04% 78.61% 85.39% 79.46% 127.80% 152.74% 199.04% 136.53%
Intangible Assets out of Total Assets
0.10 0.10 0.10 0.08 0.07 0.48 0.48 0.70 0.52 0.22
Share Based Compensation of Revenue
2.27% 3.36% 4.71% 0.00% 6.22% 8.25% 21.48% 43.17% 67.85% 41.98%
Graham Net Nets
1.20 0.70 0.76 0.30 0.09 0.01 (0.01) 0.00 0.00 0.02
Graham Number
0.00 4.44 0.00 0.00 0.00 0.00 0.00 0.00 20.99 0.00
Earnings Yield
(47.71%) 2.51% (32.48%) (44.86%) (324.47%) (30.48%) (102.96%) (2.68%) 0.07% (2.32%)
Free Cash Flow Yield
(13.64%) (0.24%) (29.12%) (87.52%) (5.68%) (2.62%) (8.04%) (0.99%) (1.10%) 0.00%
Revenue per Share
4.09 4.50 4.64 0.54 8.14 11.32 21.49 22.13 11.35 5.86
Operating CF per Share
(0.17) 0.21 (1.17) (0.27) (4.04) (9.72) (26.04) (17.16) (16.80) (3.41)
Capex per Share
(0.27) (0.22) (0.08) 0.00 (0.46) (1.56) (27.07) (36.98) (56.70) (10.53)
Free Cash Flow per Share
(0.45) (0.01) (1.26) (0.27) (4.50) (11.28) (53.11) (54.14) (73.49) (13.94)
Cash per Share
2.10 2.44 3.14 0.70 18.02 20.52 13.04 32.32 30.72 56.64
Shareholders Equity per Share
6.53 7.98 10.32 1.13 24.35 94.05 163.87 391.88 321.48 71.00
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
6.53 7.98 10.32 1.13 24.35 94.05 163.87 391.88 321.48 71.00
Free Cash Flow
(25.30) (0.59) (54.25) (87.08) (96.71) (190.79) (513.88) (458.12) (281.47) (32.39)
Working Capital
239.23 264.10 223.86 178.95 473.98 428.95 110.30 172.06 113.85 128.25
Capital Expenditures
(15.52) (12.09) (3.47) (9.12) (9.93) (26.42) (261.90) (312.92) (217.14) (24.47)
Net Current Asset Value
223.07 168.36 140.70 53.38 255.30 77.17 (176.34) (338.84) (100.74) 67.74
EV/EBIT
0.00 50.17 0.00 0.00 0.00 0.00 0.00 0.00 0.00 324.21
Capex to Sales
0.07 0.05 0.02 0.00 0.06 0.14 1.26 1.67 4.99 1.80
Price to Operating Income
0.00 67.69 0.00 0.00 0.00 0.00 0.00 0.00 0.00 330.36
Other line items
Depreciation/Fixed assets
0.15 0.10 0.13 0.10 0.40 0.16 0.12 0.12 0.05 0.02
Cash ROIC
(5.03%) (0.09%) (8.27%) (11.41%) (8.65%) (8.50%) (24.38%) (11.24%) (18.65%) (9.40%)
Accounts Receivable Turnover
7.39 7.69 6.21 5.16 4.30 4.53 3.32 3.87 6.38 7.81
Accounts Payable Turnover
2.97 2.32 3.43 6.24 3.15 3.58 2.50 0.87 0.70 0.37
Inventory Turnover
0.89 0.72 0.88 2.16 1.45 1.85 1.92 0.84 0.72 0.25
Average Days of Payables
100.39 172.56 153.98 26.98 127.45 79.27 111.65 633.23 883.61 1,588.67
Days of Inventory on Hand
347.40 560.54 490.04 158.19 255.22 188.40 183.71 685.39 804.65 2,140.09
Average Receivables
31.39 32.09 32.25 34.00 40.63 42.22 62.59 48.37 6.82 1.74
Average Payables
44.76 48.16 29.98 35.87 50.22 58.25 93.37 76.43 21.99 4.07
Average Inventory
149.28 155.00 117.58 103.77 109.03 112.38 121.12 79.51 21.46 5.99
Average Assets
523.94 617.26 658.97 776.50 1,445.00 2,054.39 3,115.91 2,830.68 874.15 149.70
Average Common Equity
403.93 441.78 405.79 444.37 1,056.98 1,588.06 2,450.64 2,273.54 698.15 84.83

Fold the line items

Columns are period end dates